Andrew Frye

Healthcare Operating Partner | CEO & Board Executive | Scaling Global MedTech & Pharma Businesses | ARCHIMED | Abbott • Baxter • DKSH

Dallas-Fort Worth Metroplex

About

I spend my time doing what I love most — taking good healthcare businesses and making them great ones. After 30 years leading commercial and operational growth across Abbott, Baxter, and DKSH in the US, Asia Pacific, and globally, I now partner with PE-backed healthcare companies as an Operating Partner at ARCHIMED and as Interim CEO at Cellese, helping leadership teams navigate transformation, scale go-to-market, and build enterprise value.

Experience

  • Operating Partner at ARCHIMED
    Sep 2024 - Present · 1 yr 10 mos

    ARCHIMED is a leading, global private equity firm focused exclusively on healthcare. Ultimately, ARCHIMED builds bigger and better healthcare businesses to deliver improved health outcomes and help people across the world.

  • Interim CEO at Cellese, Inc.
    Sep 2025 - May 2026 · 9 mos

  • Operating Partner at Sypnios Growth Capital
    Sep 2023 - Oct 2025 · 2 yrs 2 mos

  • Board Chair at Solutions Now International
    Sep 2023 - Sep 2025 · 2 yrs 1 mo

  • Medtech Advisor at Bain & Company
    Jul 2024 - Jul 2025 · 1 yr 1 mo